Satu Mustanoja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Satu Mustanoja has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Turgut Tatlisumak
Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg and Department of Neurology
9 shared publications - Daniel Strbian
Department of Neurology, Helsinki University Hospital and University of Helsinki , Helsinki
8 shared publications - Markku Kaste
Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland
8 shared publications Jukka Putaala
Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Helsinki, Finland
7 shared publications- Atte Meretoja
Department of Neurology, Helsinki University Hospital, Finland (A.M.).
6 shared publications Elena Haapaniemi
Department of Neurology, Helsinki University Central Hospital Helsinki, Finland
5 shared publications
Latest Publications
- 23 April 2018
- Published by Wiley in European Journal of Neurology
- Vol. 25 (8) , 1034-1040
Blood pressure levels in the acute phase after intracerebral hemorrhage are associated with mortality in young adults
Background and purpose: Blood pressure (BP) levels in acute intracerebral hemorrhage (ICH) and mortality have not been thoroughly studied in the young.Methods: The relationship between BP and mortality was assessed in consecutive patients with first‐ever, non‐traumatic acute ICH at ≤50 years of age, enrolled in the Helsinki ICH Young Study. BP parameters included systolic BP (SBP), diastolic BP (DBP), mean arterial pressure and pulse pressure (SBP − DBP) at admission and 24 h, and delta (admission–24 h) BP parameters. Outcome measures were 3‐month and long‐term mortalities, adjusted for demographics and ICH score parameters for short‐term and cardiovascular risk factors for long‐term prognostics. Cox regression models were used to assess independent BP parameters associated with mortality.Results: Of our 334 patients (61% male), 92 (27%) had pre‐stroke hypertension and 54 (16%) used antihypertensive treatment. The follow‐up extended to 17 years with a median of 12 (interquartile range, 9.65–14.7) years. Both 3‐month (n = 56; 16%) and long‐term (n = 97; 29%) mortalities were associated with significantly higher admission SBP and mean arterial pressure levels, but not with 24‐h BP levels, compared with survivors. Patients with SBP ≥ 160 mmHg (n = 156; 46%) had a significantly higher mortality rate (n = 59, 17% vs. n = 38, 11%; P = 0.001) and died earlier (9.6; 95% confidence interval, 2.9–12.9 years vs. 11.3; 95% confidence interval, 8.1–13.9 years; P = 0.001) within the follow‐up period. In multivariable analyses, admission SBP ≥160 mmHg was independently associated with both 3‐month (hazard ratio, 2.50; 95% confidence interval, 1.19–5.24; P < 0.05) and long‐term (hazard ratio, 2.02; 95% confidence interval, 1.18–3.43; P < 0.01) mortalities.Conclusions: In young patients with ICH, acute‐phase SBP levels ≥160 mmHg are independently associated with increased mortality.
- 23 April 2018
- Published by Wiley in European Journal of Neurology
- Vol. 25 (8) , 1034-1040
Blood pressure levels in the acute phase after intracerebral hemorrhage are associated with mortality in young adults
Background and purpose: Blood pressure (BP) levels in acute intracerebral hemorrhage (ICH) and mortality have not been thoroughly studied in the young.Methods: The relationship between BP and mortality was assessed in consecutive patients with first‐ever, non‐traumatic acute ICH at ≤50 years of age, enrolled in the Helsinki ICH Young Study. BP parameters included systolic BP (SBP), diastolic BP (DBP), mean arterial pressure and pulse pressure (SBP − DBP) at admission and 24 h, and delta (admission–24 h) BP parameters. Outcome measures were 3‐month and long‐term mortalities, adjusted for demographics and ICH score parameters for short‐term and cardiovascular risk factors for long‐term prognostics. Cox regression models were used to assess independent BP parameters associated with mortality.Results: Of our 334 patients (61% male), 92 (27%) had pre‐stroke hypertension and 54 (16%) used antihypertensive treatment. The follow‐up extended to 17 years with a median of 12 (interquartile range, 9.65–14.7) years. Both 3‐month (n = 56; 16%) and long‐term (n = 97; 29%) mortalities were associated with significantly higher admission SBP and mean arterial pressure levels, but not with 24‐h BP levels, compared with survivors. Patients with SBP ≥ 160 mmHg (n = 156; 46%) had a significantly higher mortality rate (n = 59, 17% vs. n = 38, 11%; P = 0.001) and died earlier (9.6; 95% confidence interval, 2.9–12.9 years vs. 11.3; 95% confidence interval, 8.1–13.9 years; P = 0.001) within the follow‐up period. In multivariable analyses, admission SBP ≥160 mmHg was independently associated with both 3‐month (hazard ratio, 2.50; 95% confidence interval, 1.19–5.24; P < 0.05) and long‐term (hazard ratio, 2.02; 95% confidence interval, 1.18–3.43; P < 0.01) mortalities.Conclusions: In young patients with ICH, acute‐phase SBP levels ≥160 mmHg are independently associated with increased mortality.
- Open Access
- 1 January 2017
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 8 (1) , 272
Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality
Intracerebellar haemorrhage constitutes around 10% of all spontaneous, non-aneurysmal intracerebral haemorrhages (ICHs) and often carries a grim prognosis. In symptomatic patients, surgical evacuation is usually regarded the standard treatment. Our objective was to compare the in-hospital mortality and functional outcome at hospital discharge in either medically or surgically treated patients, and the impact of either treatment on long-term mortality after a cerebellar ICH. An observational, retrospective, single-centre consecutive series of 114 patients with cerebellar ICH. We assessed the effect of different demographic factors on functional outcome and in-hospital mortality using logistic regression. We also divided the patients in medical and surgical treatment groups based on how they had been treated and compared the clinical and radiological parameters, in-hospital, and long-term mortality in the different groups. In our series, 38 patients (33.3%) underwent haematoma evacuation and 76 (66.7%) received medical treatment. Glasgow coma scale <8, blocked quadrigeminal cistern, and severe hydrocephalus were associated with in-hospital death or poor functional outcome at discharge (modified Rankin scale 4-6). Surgically treated patients were younger, had larger haematomas both in volume and diameter, were in a worse clinical condition, and suffered more from hydrocephalus and brainstem compression. There were no statistically significant differences in in-hospital or long-term mortality. However, the surgically treated patients remained in a poor clinical condition. Surgical treatment of cerebellar ICH can be life-saving but often leads to a poor functional outcome. New studies are needed on long-term functional outcome after a cerebellar ICH.
- 1 January 2017
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 8 (1) , 272
Open AccessTreatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality
Intracerebellar haemorrhage constitutes around 10% of all spontaneous, non-aneurysmal intracerebral haemorrhages (ICHs) and often carries a grim prognosis. In symptomatic patients, surgical evacuation is usually regarded the standard treatment. Our objective was to compare the in-hospital mortality and functional outcome at hospital discharge in either medically or surgically treated patients, and the impact of either treatment on long-term mortality after a cerebellar ICH. An observational, retrospective, single-centre consecutive series of 114 patients with cerebellar ICH. We assessed the effect of different demographic factors on functional outcome and in-hospital mortality using logistic regression. We also divided the patients in medical and surgical treatment groups based on how they had been treated and compared the clinical and radiological parameters, in-hospital, and long-term mortality in the different groups. In our series, 38 patients (33.3%) underwent haematoma evacuation and 76 (66.7%) received medical treatment. Glasgow coma scale <8, blocked quadrigeminal cistern, and severe hydrocephalus were associated with in-hospital death or poor functional outcome at discharge (modified Rankin scale 4-6). Surgically treated patients were younger, had larger haematomas both in volume and diameter, were in a worse clinical condition, and suffered more from hydrocephalus and brainstem compression. There were no statistically significant differences in in-hospital or long-term mortality. However, the surgically treated patients remained in a poor clinical condition. Surgical treatment of cerebellar ICH can be life-saving but often leads to a poor functional outcome. New studies are needed on long-term functional outcome after a cerebellar ICH.
- 1 June 2016
- Published by Wolters Kluwer Health in Stroke
- Vol. 47 (6) , 1593-1598
Acute-Phase Blood Pressure Levels Correlate With a High Risk of Recurrent Strokes in Young-Onset Ischemic Stroke
Background and Purpose—: High blood pressure (BP) in acute stroke has been associated with a poor outcome; however, this has not been evaluated in young adults. Methods—: The relationship between BP and long-term outcome was assessed in 1004 consecutive young, first-ever ischemic stroke patients aged 15 to 49 years enrolled in the Helsinki Young Stroke Registry. BP parameters included systolic (SBP) and diastolic BP, pulse pressure, and mean arterial pressure at admission and 24 hours. The primary outcome measure was recurrent stroke in the long-term follow-up. Adjusted for demographics and preexisting comorbidities, Cox regression models were used to assess independent BP parameters associated with outcome. Results—: Of our patients (63% male), 393 patients (39%) had prestroke hypertension and 358 (36%) used antihypertensive treatment. The median follow-up period was 8.9 years (interquartile range 5.7–13.2). Patients with a recurrent stroke (n=142, 14%) had significantly higher admission SBP, diastolic BP, pulse pressure, and mean arterial pressure ( P P P <0.001) within the follow-up period. In multivariable analyses, higher admission SBP, diastolic BP, pulse pressure, and mean arterial pressure were independently associated with the risk of recurrent stroke, while the 24-hour BP levels were not. Conclusions—: In young ischemic stroke patients, high acute phase BP levels are independently associated with a high risk of recurrent strokes.
- 1 June 2016
- Published by Wolters Kluwer Health in Stroke
- Vol. 47 (6) , 1593-1598
Acute-Phase Blood Pressure Levels Correlate With a High Risk of Recurrent Strokes in Young-Onset Ischemic Stroke
Background and Purpose—: High blood pressure (BP) in acute stroke has been associated with a poor outcome; however, this has not been evaluated in young adults. Methods—: The relationship between BP and long-term outcome was assessed in 1004 consecutive young, first-ever ischemic stroke patients aged 15 to 49 years enrolled in the Helsinki Young Stroke Registry. BP parameters included systolic (SBP) and diastolic BP, pulse pressure, and mean arterial pressure at admission and 24 hours. The primary outcome measure was recurrent stroke in the long-term follow-up. Adjusted for demographics and preexisting comorbidities, Cox regression models were used to assess independent BP parameters associated with outcome. Results—: Of our patients (63% male), 393 patients (39%) had prestroke hypertension and 358 (36%) used antihypertensive treatment. The median follow-up period was 8.9 years (interquartile range 5.7–13.2). Patients with a recurrent stroke (n=142, 14%) had significantly higher admission SBP, diastolic BP, pulse pressure, and mean arterial pressure ( P P P <0.001) within the follow-up period. In multivariable analyses, higher admission SBP, diastolic BP, pulse pressure, and mean arterial pressure were independently associated with the risk of recurrent stroke, while the 24-hour BP levels were not. Conclusions—: In young ischemic stroke patients, high acute phase BP levels are independently associated with a high risk of recurrent strokes.
- Open Access
- 30 May 2015
- Published by Wiley in Brain and Behavior
- Vol. 5 (8) , e00349
Helsinki experience on nonvitamin K oral anticoagulants for treating cervical artery dissection
Background: Cervical artery dissection (CeAD) patients with or without stroke are frequently treated with either antiplatelet agents or vitamin K antagonists (VKAs), but few data are reported on the use of nonvitamin K oral anticoagulants (NOACs).Methods: Between November 2011 and January 2014, we recorded data from patients with a stroke due to vertebral (VAD) or internal carotid artery dissection (ICAD). Patients using oral anticoagulants were included in the study and were divided into two treatment groups: patients using NOACs and those using VKAs. Excellent outcome was defined on modified Rankin Scale (mRS) ≤1 at 6 months.Results: Of 68 stroke patients (67% male; median age 45 [39–53]), six (8.8%; two with VAD and four with ICAD) were treated with NOACs: three with direct thrombin inhibitor dabigatran and three with direct factor Xa inhibitor rivaroxaban. National Institutes of Health Stroke Scale score at baseline was 4 (3–7) in the NOAC versus 2 (1–7) in the VKA groups. Complete recanalization at 6 months was seen in most patients in the NOAC (n = 5; 83%) and VKA (n = 34; 55%) groups. All the patients using NOACs had mRS ≤1 at 6 months and none had an intracerebral hemorrhage (ICH). In the VKA group most patients (n = 48; 77%) had mRS ≤1, one patient (1.7%) had an ICH and one died.Conclusions: In this small, consecutive single‐center patient sample treating ischemic stroke patients with CeAD with NOACs did not bring up safety concerns and resulted in similar, good outcomes compared to patients using VKAs.
- 30 May 2015
- Published by Wiley in Brain and Behavior
- Vol. 5 (8) , e00349
Open AccessHelsinki experience on nonvitamin K oral anticoagulants for treating cervical artery dissection
Background: Cervical artery dissection (CeAD) patients with or without stroke are frequently treated with either antiplatelet agents or vitamin K antagonists (VKAs), but few data are reported on the use of nonvitamin K oral anticoagulants (NOACs).Methods: Between November 2011 and January 2014, we recorded data from patients with a stroke due to vertebral (VAD) or internal carotid artery dissection (ICAD). Patients using oral anticoagulants were included in the study and were divided into two treatment groups: patients using NOACs and those using VKAs. Excellent outcome was defined on modified Rankin Scale (mRS) ≤1 at 6 months.Results: Of 68 stroke patients (67% male; median age 45 [39–53]), six (8.8%; two with VAD and four with ICAD) were treated with NOACs: three with direct thrombin inhibitor dabigatran and three with direct factor Xa inhibitor rivaroxaban. National Institutes of Health Stroke Scale score at baseline was 4 (3–7) in the NOAC versus 2 (1–7) in the VKA groups. Complete recanalization at 6 months was seen in most patients in the NOAC (n = 5; 83%) and VKA (n = 34; 55%) groups. All the patients using NOACs had mRS ≤1 at 6 months and none had an intracerebral hemorrhage (ICH). In the VKA group most patients (n = 48; 77%) had mRS ≤1, one patient (1.7%) had an ICH and one died.Conclusions: In this small, consecutive single‐center patient sample treating ischemic stroke patients with CeAD with NOACs did not bring up safety concerns and resulted in similar, good outcomes compared to patients using VKAs.
- 12 January 2015
- Published by SAGE Publications in International Journal of Stroke
- Vol. 10 (4) , 576-581
Extent of Secondary Intraventricular Hemorrhage is an Independent Predictor of Outcomes in Intracerebral Hemorrhage: Data from the Helsinki ICH Study
Background: Intraventricular hemorrhage is a severe subtype of intracerebral hemorrhage associated with high mortality and poor outcome. Aim: We analyzed various intraventricular hemorrhage scores at baseline to find common parameters associated with increased mortality. Methods: Consecutive intracerebral hemorrhage patients treated in Helsinki University Central Hospital during 2005— 2010 were included in the Helsinki Intracerebral Hemorrhage Study registry and analyzed for three-month mortality. Results After excluding lost-to-follow-up patients, 967 intracerebral hemorrhage patients were included, out of whom 398 (41%) had intraventricular hemorrhage. Intraventricular hemorrhage patients, compared with nonintraventricular hemorrhage patients, had lower baseline Glasgow Coma Scale [median 12 (IQR 6–15) vs. 15 (13–15); P < 0·001] and higher National Institutes of Health Stroke Scale [18 (10–27) vs. 7 (3–14); P < 0·001] scores; larger intracerebral hemorrhage volumes [17 ml (7·2–42) vs. 6·8 (2·4–18); P < 0·001] and more often hydrocephalus (51% vs. 9%; P < 0·001); and higher mortality rates (54% vs. 18%; P < 0·001). In multivariable analysis, the presence of intraventricular hemorrhage was independently associated with mortality [OR 2·05 (95% CI 1·36–3·09)] when adjusted for well-known prognostic factors of intracerebral hemorrhage, i.e. age, gender, baseline National Institutes of Health Stroke Scale, intracerebral hemorrhage volume, infratentorial location, and etiology. Conclusions: The presence of intraventricular hemorrhage was independently associated with increased mortality, and all the intraventricular hemorrhage scores were strong predictors of three-month mortality.
- 12 January 2015
- Published by SAGE Publications in International Journal of Stroke
- Vol. 10 (4) , 576-581
Extent of Secondary Intraventricular Hemorrhage is an Independent Predictor of Outcomes in Intracerebral Hemorrhage: Data from the Helsinki ICH Study
Background: Intraventricular hemorrhage is a severe subtype of intracerebral hemorrhage associated with high mortality and poor outcome. Aim: We analyzed various intraventricular hemorrhage scores at baseline to find common parameters associated with increased mortality. Methods: Consecutive intracerebral hemorrhage patients treated in Helsinki University Central Hospital during 2005— 2010 were included in the Helsinki Intracerebral Hemorrhage Study registry and analyzed for three-month mortality. Results After excluding lost-to-follow-up patients, 967 intracerebral hemorrhage patients were included, out of whom 398 (41%) had intraventricular hemorrhage. Intraventricular hemorrhage patients, compared with nonintraventricular hemorrhage patients, had lower baseline Glasgow Coma Scale [median 12 (IQR 6–15) vs. 15 (13–15); P < 0·001] and higher National Institutes of Health Stroke Scale [18 (10–27) vs. 7 (3–14); P < 0·001] scores; larger intracerebral hemorrhage volumes [17 ml (7·2–42) vs. 6·8 (2·4–18); P < 0·001] and more often hydrocephalus (51% vs. 9%; P < 0·001); and higher mortality rates (54% vs. 18%; P < 0·001). In multivariable analysis, the presence of intraventricular hemorrhage was independently associated with mortality [OR 2·05 (95% CI 1·36–3·09)] when adjusted for well-known prognostic factors of intracerebral hemorrhage, i.e. age, gender, baseline National Institutes of Health Stroke Scale, intracerebral hemorrhage volume, infratentorial location, and etiology. Conclusions: The presence of intraventricular hemorrhage was independently associated with increased mortality, and all the intraventricular hemorrhage scores were strong predictors of three-month mortality.
- 1 October 2014
- Published by SAGE Publications in International Journal of Stroke
- Vol. 9 (SA100) , 85-92
Haemorrhagic Transformation of Ischaemic Stroke in Young Adults
Background: Frequency, factors associated with, and impact on outcome of haemorrhagic transformation in young adults with ischaemic stroke are unknown. Methods: Consecutive young patients (age 15–49) with first-ever ischaemic stroke were included, having their first brain computed tomography/magnetic resonance imaging within seven-days of stroke onset, and second within seven-days from the first imaging. Haemorrhagic transformation in any imaging was classified as haemorrhagic infarct or parenchymal haemorrhage within or remote from the infarct. Symptomatic haemorrhagic transformation was defined according to the European Cooperative Acute Stroke Study II (ECASS II) criteria as any haemorrhage leading to a National Institutes of Health Stroke Scale score increase of ≥4 points or death. Unfavourable three-month outcome was defined as a modified Rankin Scale 2–6. Results: In 636 eligible patients, any haemorrhagic transformation occurred in 79 patients (12·4%; 10·0–15·2%): 66 (10·4%; 8·24–12·9%) had haemorrhagic infarct, and 13 (2·04%; 1·19–3·46%) had parenchymal haemorrhage. Symptomatic haemorrhagic transformation occurred in 16 patients (2·5%; 4·04–1·55%). In logistic regression analysis, independent factors associated with haemorrhagic transformation were large anterior (18·70; 6·72–52·04), large posterior (9·41; 3·13–28·25), medium-sized (odds ratio 3·30; 95% confidence interval 1·14–9·57) lesions, higher low-density lipoprotein level (1·44 per unit increment; 1·10–1·90), and lower platelet count (1·005 per unit decrement; 1·009–1·001). Haemorrhagic infarct (1·76; 0·76–4·11) or parenchymal haemorrhage (2·39; 0·23–24·76) were not associated with unfavourable functional outcome or death at three-months. Conclusions: In young adults, haemorrhagic transformation of ischaemic stroke occurred in comparable rates to haemorrhagic transformation in elderly patients. Although haemorrhagic transformation was more common in severe strokes, it was the lesion size and baseline stroke severity that were associated with three-month clinical outcome, not haemorrhagic transformation per se.
- 1 October 2014
- Published by SAGE Publications in International Journal of Stroke
- Vol. 9 (SA100) , 85-92
Haemorrhagic Transformation of Ischaemic Stroke in Young Adults
Background: Frequency, factors associated with, and impact on outcome of haemorrhagic transformation in young adults with ischaemic stroke are unknown. Methods: Consecutive young patients (age 15–49) with first-ever ischaemic stroke were included, having their first brain computed tomography/magnetic resonance imaging within seven-days of stroke onset, and second within seven-days from the first imaging. Haemorrhagic transformation in any imaging was classified as haemorrhagic infarct or parenchymal haemorrhage within or remote from the infarct. Symptomatic haemorrhagic transformation was defined according to the European Cooperative Acute Stroke Study II (ECASS II) criteria as any haemorrhage leading to a National Institutes of Health Stroke Scale score increase of ≥4 points or death. Unfavourable three-month outcome was defined as a modified Rankin Scale 2–6. Results: In 636 eligible patients, any haemorrhagic transformation occurred in 79 patients (12·4%; 10·0–15·2%): 66 (10·4%; 8·24–12·9%) had haemorrhagic infarct, and 13 (2·04%; 1·19–3·46%) had parenchymal haemorrhage. Symptomatic haemorrhagic transformation occurred in 16 patients (2·5%; 4·04–1·55%). In logistic regression analysis, independent factors associated with haemorrhagic transformation were large anterior (18·70; 6·72–52·04), large posterior (9·41; 3·13–28·25), medium-sized (odds ratio 3·30; 95% confidence interval 1·14–9·57) lesions, higher low-density lipoprotein level (1·44 per unit increment; 1·10–1·90), and lower platelet count (1·005 per unit decrement; 1·009–1·001). Haemorrhagic infarct (1·76; 0·76–4·11) or parenchymal haemorrhage (2·39; 0·23–24·76) were not associated with unfavourable functional outcome or death at three-months. Conclusions: In young adults, haemorrhagic transformation of ischaemic stroke occurred in comparable rates to haemorrhagic transformation in elderly patients. Although haemorrhagic transformation was more common in severe strokes, it was the lesion size and baseline stroke severity that were associated with three-month clinical outcome, not haemorrhagic transformation per se.
- 1 August 2014
- Published by Wolters Kluwer Health in Stroke
- Vol. 45 (8) , 2454-2456
Predictors of Early Mortality in Young Adults After Intracerebral Hemorrhage
Background and Purpose—: Patient and radiological characteristics of intracerebral hemorrhage (ICH), surgical treatment, and outcome after ICH are interrelated. Our purpose was to define whether these characteristics or surgical treatment correlate with mortality among young adults. Methods—: We retrospectively reviewed clinical and imaging data of all first-ever nontraumatic patients with ICH between 16 and 49 years of age treated in our hospital between January 2000 and March 2010 and linked these data with national causes of death registry. A logistic regression analysis of factors associated with 3-month mortality and a propensity score comparison between patients treated conservatively and operatively was performed. Results—: Among the 325 eligible patients (59.4% men), factors associated with 3-month mortality included higher National Institutes of Health Stroke Scale score, infratentorial location, hydrocephalus, herniation, and multiple hemorrhages. Adjusted for these factors, as well as demographics, ICH volume, and the underlying cause, surgical evacuation was associated with lower 3-month mortality (odds ratio, 0.06; 95% confidence interval, 0.02–0.21). In propensity score–matched analysis, 3-month case fatality rates were 3-fold in those treated conservatively (27.5% versus 7.8%; P <0.001). Conclusions—: The predictors of short-term case fatality are alike in young and elderly patients with ICH. However, initial hematoma evacuation was associated with lower 3-month case fatality in our young patients with ICH.
- 1 August 2014
- Published by Wolters Kluwer Health in Stroke
- Vol. 45 (8) , 2454-2456
Predictors of Early Mortality in Young Adults After Intracerebral Hemorrhage
Background and Purpose—: Patient and radiological characteristics of intracerebral hemorrhage (ICH), surgical treatment, and outcome after ICH are interrelated. Our purpose was to define whether these characteristics or surgical treatment correlate with mortality among young adults. Methods—: We retrospectively reviewed clinical and imaging data of all first-ever nontraumatic patients with ICH between 16 and 49 years of age treated in our hospital between January 2000 and March 2010 and linked these data with national causes of death registry. A logistic regression analysis of factors associated with 3-month mortality and a propensity score comparison between patients treated conservatively and operatively was performed. Results—: Among the 325 eligible patients (59.4% men), factors associated with 3-month mortality included higher National Institutes of Health Stroke Scale score, infratentorial location, hydrocephalus, herniation, and multiple hemorrhages. Adjusted for these factors, as well as demographics, ICH volume, and the underlying cause, surgical evacuation was associated with lower 3-month mortality (odds ratio, 0.06; 95% confidence interval, 0.02–0.21). In propensity score–matched analysis, 3-month case fatality rates were 3-fold in those treated conservatively (27.5% versus 7.8%; P <0.001). Conclusions—: The predictors of short-term case fatality are alike in young and elderly patients with ICH. However, initial hematoma evacuation was associated with lower 3-month case fatality in our young patients with ICH.
- 21 January 2014
- Published by Wiley in European Journal of Neurology
- Vol. 21 (4) , 616-622
Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use
Background and purpose: Intracerebral hemorrhage (ICH) is the most feared complication of oral anticoagulation (OAC). Our aim was to investigate the impact of the international normalized ratio (INR) level on mortality in OAC‐associated ICH compared with non‐OAC‐associated ICH.Methods: A retrospective chart review of consecutive ICH patients treated at the Helsinki University Central Hospital from January 2005 to March 2010 (n = 1013) was performed. An ICH was considered to be OAC‐associated if the patient was on warfarin at ICH onset. The association of INR with 3‐month mortality was adjusted in a multivariable logistic regression model for factors influencing the crude odds ratios (ORs) in bivariable logistic regression by more than 5%.Results: One in eight ICHs was OAC‐associated (n = 132). Of these, 50% had therapeutic INR (2.0–3.0), 7% had INR 3.0) on admission. Patients on OAC were older (median 76 vs. 66 years; P < 0.001) with more severe symptoms (median National Institutes of Health Stroke Scale 14 vs. 10; P < 0.001) and larger hematomas (median 11.4 vs. 9.7 ml; P < 0.001) on admission than patients not on OAC. After adjustment for confounders, 3‐month mortality in the whole cohort was associated with higher baseline INR (OR 1.06; CI 1.03–1.09 per 0.1 increment). Mortality was higher with both therapeutic (51% at 3 months; OR 3.59; CI 1.50–8.60) and high (61%; OR 5.26; CI 1.94–14.27) INR values compared with non‐OAC‐associated ICH (29%).Conclusions: Patients with OAC‐associated ICH had more severe strokes and higher mortality compared with patients with ICH not related to OAC. Higher baseline INR was associated with increased 3‐month mortality.
- 21 January 2014
- Published by Wiley in European Journal of Neurology
- Vol. 21 (4) , 616-622
Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use
Background and purpose: Intracerebral hemorrhage (ICH) is the most feared complication of oral anticoagulation (OAC). Our aim was to investigate the impact of the international normalized ratio (INR) level on mortality in OAC‐associated ICH compared with non‐OAC‐associated ICH.Methods: A retrospective chart review of consecutive ICH patients treated at the Helsinki University Central Hospital from January 2005 to March 2010 (n = 1013) was performed. An ICH was considered to be OAC‐associated if the patient was on warfarin at ICH onset. The association of INR with 3‐month mortality was adjusted in a multivariable logistic regression model for factors influencing the crude odds ratios (ORs) in bivariable logistic regression by more than 5%.Results: One in eight ICHs was OAC‐associated (n = 132). Of these, 50% had therapeutic INR (2.0–3.0), 7% had INR 3.0) on admission. Patients on OAC were older (median 76 vs. 66 years; P < 0.001) with more severe symptoms (median National Institutes of Health Stroke Scale 14 vs. 10; P < 0.001) and larger hematomas (median 11.4 vs. 9.7 ml; P < 0.001) on admission than patients not on OAC. After adjustment for confounders, 3‐month mortality in the whole cohort was associated with higher baseline INR (OR 1.06; CI 1.03–1.09 per 0.1 increment). Mortality was higher with both therapeutic (51% at 3 months; OR 3.59; CI 1.50–8.60) and high (61%; OR 5.26; CI 1.94–14.27) INR values compared with non‐OAC‐associated ICH (29%).Conclusions: Patients with OAC‐associated ICH had more severe strokes and higher mortality compared with patients with ICH not related to OAC. Higher baseline INR was associated with increased 3‐month mortality.
- 1 August 2013
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (8) , 2330-2332
Association of Prestroke Statin Use and Lipid Levels With Outcome of Intracerebral Hemorrhage
Background and Purpose—: It is unclear whether blood lipid profiles and statin use before intracerebral hemorrhage (ICH) are associated with its outcome. Methods—: The Helsinki ICH Study, a single-center observational registry of consecutive ICH patients, was used to study the associations between premorbid statin use, baseline lipid levels, and clinical outcome. Results—: The registry includes 964 ICH patients. Statin users (n=187; 19%) were significantly older, had more frequent comorbidities and medication, lower lipid levels, and higher admission Glasgow Coma Scale compared with nonusers. Modified Rankin Scale at discharge or mortality did not differ between statin users and nonusers. Compared with survivors, significantly lower total cholesterol and low-density lipoprotein cholesterol levels were observed in patients who died in hospital (median, 4.1 mmol/L [interquartile range, 3.6–4.4] versus 4.5 [3.8–5.1]; P P P =0.028). Conclusions—: Premorbid statin use did not affect the outcome of ICH, but lower low-density lipoprotein levels were associated with higher in-hospital mortality.
- 1 August 2013
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (8) , 2330-2332
Association of Prestroke Statin Use and Lipid Levels With Outcome of Intracerebral Hemorrhage
Background and Purpose—: It is unclear whether blood lipid profiles and statin use before intracerebral hemorrhage (ICH) are associated with its outcome. Methods—: The Helsinki ICH Study, a single-center observational registry of consecutive ICH patients, was used to study the associations between premorbid statin use, baseline lipid levels, and clinical outcome. Results—: The registry includes 964 ICH patients. Statin users (n=187; 19%) were significantly older, had more frequent comorbidities and medication, lower lipid levels, and higher admission Glasgow Coma Scale compared with nonusers. Modified Rankin Scale at discharge or mortality did not differ between statin users and nonusers. Compared with survivors, significantly lower total cholesterol and low-density lipoprotein cholesterol levels were observed in patients who died in hospital (median, 4.1 mmol/L [interquartile range, 3.6–4.4] versus 4.5 [3.8–5.1]; P P P =0.028). Conclusions—: Premorbid statin use did not affect the outcome of ICH, but lower low-density lipoprotein levels were associated with higher in-hospital mortality.
- 11 October 2012
- Published by Wiley in European Journal of Neurology
- Vol. 20 (2) , 216-222
Multiple brain infarcts in young adults: clues for etiologic diagnosis and prognostic impact
Background and purpose There are little data on the etiology of multiple brain infarcts (MBI) and their impact on clinical outcome in young patients. Methods We studied 548 MRI‐imaged patients (15–49 years) with a first‐ever ischaemic stroke. Ischaemic lesions were categorized into three groups: single lesions, MBI in one or >1 circulation territories. Outcomes were unfavorable 3‐month modified Rankin Scale (mRS) score of ≥2 and, during long‐term follow‐up (mean 8.20 ± 4.01 years), recurrent ischaemic stroke or death from any cause. Results Multiple brain infarcts occurred in 185 patients (33.8%; mean age 39.2 ± 8.2), of which 144 patients (26.3%) had lesions located in a single territory and 41 patients (7.5%) in multiple territories. Patients with MBI in a single territory were more likely than patients with single lesions to have a high‐risk source of cardioembolism (CE) (9.0% vs. 3.0%; P = 0.001), large‐artery atherosclerosis (8.3% vs. 4.9%; P = 0.012), vertebral (22% vs. 10%; P < 0.001) or carotid artery dissections (8.3% vs. 6.3%; P = 0.036), and MBI in multiple territories a high‐risk source of CE (34% vs. 3.0%, P < 0.001). Adjusted for age, gender, baseline stroke severity, size of the largest lesion, and stroke subtype, MBI remained independently associated with an unfavorable 3‐month outcome (odds ratio 2.84, 95% confidence interval 1.22–6.61). In multivariate Cox proportional hazards analysis, MBI had independent influence on the risk for death (hazard ratio 3.75, 1.58–8.86), but not on recurrent ischaemic stroke. Conclusions Compared with the elderly, young stroke patients have a distinct stroke etiology underlying MBI, being an independent indicator of poor short‐term outcome and long‐term risk of death.
- 11 October 2012
- Published by Wiley in European Journal of Neurology
- Vol. 20 (2) , 216-222
Multiple brain infarcts in young adults: clues for etiologic diagnosis and prognostic impact
Background and purpose There are little data on the etiology of multiple brain infarcts (MBI) and their impact on clinical outcome in young patients. Methods We studied 548 MRI‐imaged patients (15–49 years) with a first‐ever ischaemic stroke. Ischaemic lesions were categorized into three groups: single lesions, MBI in one or >1 circulation territories. Outcomes were unfavorable 3‐month modified Rankin Scale (mRS) score of ≥2 and, during long‐term follow‐up (mean 8.20 ± 4.01 years), recurrent ischaemic stroke or death from any cause. Results Multiple brain infarcts occurred in 185 patients (33.8%; mean age 39.2 ± 8.2), of which 144 patients (26.3%) had lesions located in a single territory and 41 patients (7.5%) in multiple territories. Patients with MBI in a single territory were more likely than patients with single lesions to have a high‐risk source of cardioembolism (CE) (9.0% vs. 3.0%; P = 0.001), large‐artery atherosclerosis (8.3% vs. 4.9%; P = 0.012), vertebral (22% vs. 10%; P < 0.001) or carotid artery dissections (8.3% vs. 6.3%; P = 0.036), and MBI in multiple territories a high‐risk source of CE (34% vs. 3.0%, P < 0.001). Adjusted for age, gender, baseline stroke severity, size of the largest lesion, and stroke subtype, MBI remained independently associated with an unfavorable 3‐month outcome (odds ratio 2.84, 95% confidence interval 1.22–6.61). In multivariate Cox proportional hazards analysis, MBI had independent influence on the risk for death (hazard ratio 3.75, 1.58–8.86), but not on recurrent ischaemic stroke. Conclusions Compared with the elderly, young stroke patients have a distinct stroke etiology underlying MBI, being an independent indicator of poor short‐term outcome and long‐term risk of death.